ENDEFR
Home › Singapore › BAXTER PHARMACEUTICAL (ASIA) PTE. LTD.

BAXTER PHARMACEUTICAL (ASIA) PTE. LTD.

Private Company Limited by Shares · SINGAPORE, Singapore · LEI 875500Y1TMQ2D6QNIK77
LEI active

Summary

BAXTER PHARMACEUTICAL (ASIA) PTE. LTD. is registered in Singapore and entered in the “Business Registry (ACRA)” under number 201705750R. Its legal form is Private Company Limited by Shares. According to GLEIF, its ultimate parent is BAXTER INTERNATIONAL INC. (United States), which is also its direct parent. That group has 9 subsidiaries with LEIs in 7 countries, 1 of them in Singapore. The LEI was first issued on 8 Apr 2019 and the record was last updated on 10 Apr 2026; the next renewal is due by 14 Apr 2027.

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

No data-quality notes for this entity in this data release.

Company details

Legal formPrivate Company Limited by Shares
RegisterBusiness Registry (ACRA) · Register website
Registration number201705750R
Registration authorityAccounting and Corporate Regulatory Authority (ACRA)
JurisdictionSingapore
Registered address80 PASIR PANJANG ROAD #26-81, MAPLETREE BUSINESS CITY, 117372 SINGAPORE, Singapore
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)1 Mar 2017
LEI875500Y1TMQ2D6QNIK77
LEI statusactive
LEI first issued8 Apr 2019
LEI record last updated10 Apr 2026
Next LEI renewal14 Apr 2027
Corroboration of the LEI recordfully corroborated

Group membership

BAXTER INTERNATIONAL INC. United States ultimate parent
BAXTER PHARMACEUTICAL (ASIA) PTE. LTD. this entity
View the whole group: 9 subsidiaries in 7 countries

Relationship to the parent

Direct parentUltimate parent
ParentBAXTER INTERNATIONAL INC.BAXTER INTERNATIONAL INC.
Accounting period1 Jan 2025 to 31 Dec 20251 Jan 2025 to 31 Dec 2025
Evidenceconsolidated accountsconsolidated accounts
Corroborationsupplied by the entity onlysupplied by the entity only
Relationship start1 Mar 20171 Mar 2017
Recorded at GLEIF since9 Dec 20249 Dec 2024
Last updated10 Apr 202610 Apr 2026
Record statuscurrentcurrent

Other subsidiaries of the same direct parent (6)